RU93043630A - METHOD OF IMPROVING MEMORY PROCESSES - Google Patents

METHOD OF IMPROVING MEMORY PROCESSES

Info

Publication number
RU93043630A
RU93043630A RU93043630/14A RU93043630A RU93043630A RU 93043630 A RU93043630 A RU 93043630A RU 93043630/14 A RU93043630/14 A RU 93043630/14A RU 93043630 A RU93043630 A RU 93043630A RU 93043630 A RU93043630 A RU 93043630A
Authority
RU
Russia
Prior art keywords
memory processes
improving memory
living organism
drug
processes
Prior art date
Application number
RU93043630/14A
Other languages
Russian (ru)
Other versions
RU2071319C1 (en
Inventor
Е.Б. Бурлакова
К.З. Гумаргалиева
А.Н. Иноземцев
О.В. Карпухина
А.Г. Соловьев
Л.Л. Прагина
Н.А. Тушмалова
Original Assignee
Акционерное общество закрытого типа "Химбио", г.Москва
Биологический факультет Московского государственного университета им.М.В.Ломоносова
Filing date
Publication date
Application filed by Акционерное общество закрытого типа "Химбио", г.Москва, Биологический факультет Московского государственного университета им.М.В.Ломоносова filed Critical Акционерное общество закрытого типа "Химбио", г.Москва
Priority to RU93043630A priority Critical patent/RU2071319C1/en
Priority claimed from RU93043630A external-priority patent/RU2071319C1/en
Publication of RU93043630A publication Critical patent/RU93043630A/en
Application granted granted Critical
Publication of RU2071319C1 publication Critical patent/RU2071319C1/en

Links

Claims (1)

Изобретение относится к медицине и может использоваться для улучшения процессов памяти. Цель изобретения - удешевление курса лечения за счет уменьшения расхода препарата. Способ заключается во внутримышечном введении психотропного препарата пирацетама в живой организм в количестве, не превышающем 0,2 мг на 1 кг массы живого организма.The invention relates to medicine and can be used to improve memory processes. The purpose of the invention is to reduce the cost of treatment by reducing the consumption of the drug. The method consists in the intramuscular administration of the psychotropic drug piracetam into a living organism in an amount not exceeding 0.2 mg per 1 kg of the weight of the living organism.
RU93043630A 1993-08-31 1993-08-31 Method of memory process improvement RU2071319C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93043630A RU2071319C1 (en) 1993-08-31 1993-08-31 Method of memory process improvement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93043630A RU2071319C1 (en) 1993-08-31 1993-08-31 Method of memory process improvement

Publications (2)

Publication Number Publication Date
RU93043630A true RU93043630A (en) 1996-06-10
RU2071319C1 RU2071319C1 (en) 1997-01-10

Family

ID=20147136

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93043630A RU2071319C1 (en) 1993-08-31 1993-08-31 Method of memory process improvement

Country Status (1)

Country Link
RU (1) RU2071319C1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US8535708B2 (en) 2004-12-29 2013-09-17 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
JP5284087B2 (en) 2005-07-14 2013-09-11 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド Ways to prolong animal life

Similar Documents

Publication Publication Date Title
GEP20002300B (en) Purified Forms of Dnase, Method for Its Production, Pharmaceutical Composition and Use Thereof
RU94028105A (en) NEW HETEROARYL DERIVATIVES, INTERMEDIATE CONNECTIONS FOR THEIR RECEPTION, PHARMACEUTICAL ON THEIR BASIS, METHOD OF TREATING PSYCHOSES AND METHOD OF LIGHTENING PAIN
UA41446C2 (en) Use of fumagilol or its derivatives for preparing drugs intended for treating intestinal infection and pharmaceutical composition
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
RU94002133A (en) 6-CHLOR-5-FTOR-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE AS AN ANALOGESIC AND ANIMATERATIVE MEDICATION
RU93043630A (en) METHOD OF IMPROVING MEMORY PROCESSES
MD990258A (en) Method of treatment of the acute viral hepatitis B
CA2108330A1 (en) Enhancer for the Antianemia Effect of Erythropoietin and Method of Augmenting the Antianemia Effect of Erythropoietin
ATE49884T1 (en) USE OF SACCHAROMYCES YEAST FOR THE MANUFACTURE OF AN AGAINST AMOEBIASIS MEDICINAL PRODUCT.
KR960003718A (en) Use of Ifenprodil and its Diastereomers for the Preparation of Medicines Useful for the Treatment of Peripheral and Central Neurodegenerative Diseases
HU9500120D0 (en) Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
RU95120783A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
RU93002333A (en) RIDOSTIN INTERFER Inductor
NO960347L (en) Use of benzydamide in the treatment of pathological conditions caused by TNF
RU93029906A (en) METHOD OF TREATMENT OF DUODENAL DISORDER DISTURBANCES IN ULCERAL DISEASE AND POST-GAS SYNDROME
RU93003437A (en) Method of suppressing lesion to ethanol and abstinent syndrome through adaptation to periodic hypoxia
RU95113855A (en) METHOD FOR CONSERVATIVE TREATMENT OF EYE BURNS
RU97112609A (en) METHOD FOR TREATING "METABOLIC SYNDROME X"
Wang Fluorosis and the tea-drinking habit among Kazaks in Xinjiang
RU93025025A (en) METHOD FOR REDUCING DRUG COSTS WITH MYOCARDIAL INFARCTION
RU97116119A (en) DRUG FOR THE TREATMENT OF ANIMAL PYROPLASMIDOSIS AND METHOD OF ITS APPLICATION
RU97112310A (en) METHOD FOR TREATING ULCER DISEASE
RU93012483A (en) COLLECTION OF MEDICINAL PLANTS "ANNA" USED AT HEADACHES
RU93058154A (en) METHOD FOR TREATING EARLY ACQUIRED FORMS OF SYPHILIS
RU93018067A (en) METHOD OF TREATMENT FOR CAVIARY FORM OF TUBERCULOSIS